imatinib mesylate has been researched along with Paraplegia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appay, R; Aubert, S; Bouvier, C; Delteil, C; Macagno, N; Magis, Q; Malissen, N; Richard, MA | 1 |
1 other study(ies) available for imatinib mesylate and Paraplegia
Article | Year |
---|---|
[Chordoma cutis, an unusual clinical presentation of a rare neoplasm: Chordoma].
Topics: Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chordoma; Combined Modality Therapy; Contraindications, Procedure; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Paraplegia; Radiotherapy, Adjuvant; Sacrococcygeal Region; Skin Neoplasms; Skin Ulcer; Soft Tissue Neoplasms | 2018 |